公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015 | BOR-SHENG KO ; Chen L.-J.; HUAI-HSUAN HUANG ; Chen H.-M.; FEI-YUAN HSIAO | International Journal of Clinical Practice | 9 | 6 | |
2022 | The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan | HUAI-HSUAN HUANG ; Chen C.-M.; Wang C.-Y.; Hsu W.W.-Y.; Chen H.-M.; BOR-SHENG KO ; FEI-YUAN HSIAO | PLoS ONE | 4 | 4 | |
2020 | False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration | WANG-DA LIU ; SHU-WEN LIN ; Shih, M. C.; Su, C. L.; Wang, Y. W.; Lin, S. C.; Lee, Y. F.; HUAI-HSUAN HUANG ; WEN-CHIEN CHOU ; UN-IN WU ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Clinical Microbiology and Infection | 12 | 8 | |
2020 | Frontline treatments in extremely elderly patients with diffuse large B-cell lymphoma: A population-based study in Taiwan, 2010-2015 | HUAI-HSUAN HUANG ; BOR-SHENG KO ; Chen H.-M.; Chen L.-J.; Wang C.-Y.; Hsiao F.-Y.; FEI-YUAN HSIAO | Immunity and Ageing | 5 | 5 | |
2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
2022 | Management of metastatic renal cell carcinoma following prior vascular endothelial growth factor-targeted therapy: A real-world retrospective study from Taiwan | Chung H.-J.; Chang Y.-H.; Huang Y.-H.; Lin T.-P.; Wei T.-C.; FANG-JU LIN ; HUAI-HSUAN HUANG ; Wang H.-C. | Journal of the Chinese Medical Association : JCMA | 4 | 3 | |
2021 | Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015 | Wang C.-Y.; HUAI-HSUAN HUANG ; Chen H.-M.; FEI-YUAN HSIAO ; BOR-SHENG KO | Clinical Lymphoma, Myeloma and Leukemia | 1 | 0 | |
2023 | Risk of thromboembolic events associated with different multiple myeloma regimens in Taiwan: a nested case-control study | Chen, Mei-Tsen; Huang, Shih-Tsung; HUAI-HSUAN HUANG ; WEN-JONE CHEN ; BOR-SHENG KO ; Hsiao, Fei-Yuan | Journal of thrombosis and thrombolysis | 1 | 0 | |
2018 | Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real-world analysis from Taiwan Cancer Registry Database | HUAI-HSUAN HUANG ; Wen Y.-C.; Chen H.-M.; FEI-YUAN HSIAO ; BOR-SHENG KO | Cancer Medicine | 6 | 5 | |
2018 | Subtype-specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002-2012 | BOR-SHENG KO ; Chen L.-J.; HUAI-HSUAN HUANG ; Wen Y.-C.; Liao C.-Y.; Chen H.-M.; FEI-YUAN HSIAO | Cancer Medicine | 12 | 8 | |
2021 | Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population-Based, Propensity Score-Matched Cohort Study | Chen, Mei-Tsen; Huang, Shih-Tsung; Lin, Chih-Wan; BOR-SHENG KO ; WEN-JONE CHEN ; HUAI-HSUAN HUANG ; FEI-YUAN HSIAO | The oncologist | 7 | 5 | |
2019 | Women with diffuse large B cell lymphoma benefit more from rituximab-containing chemotherapy | HUAI-HSUAN HUANG ; FEI-YUAN HSIAO ; Chen L.-J.; Chen H.-M.; BOR-SHENG KO | Journal of Women's Health | 5 | 6 | |